Investors
Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations.
Investor news
See our latest Investor presentations, webcast, transcripts and interviews.
Press release - November 27, 2024
Oncopeptides obtains reimbursement for Pepaxti in Italy
Read press release
Investor Relations Contact
David Augustsson
Director of Corporate Affairs
The share
Oncopeptides is listed on Nasdaq Stockholm Small Cap under the trade symbol ONCO, since February 22, 2017.
Financial reports
See all of our financial reports together with related documents and webcasts.
Upcoming events
2025-01-28 - 2025-02-26
Silent period
Other
2025-02-27
Year-end Report 2024
Report
2025-04-08 - 2025-05-07
Silent period
Other